Earlier this year, Henry Schein completed the acquisition of orthopedic player TriMed. With the integration of TriMed’s business, the company is now able to provide a wide range of surgical ...
Jefferies analyst Glen Santangelo assigned a Hold rating to Henry Schein (HSIC – Research Report) today and set a price target of $80.00. The ...